About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  SMART QUOTES
Smart Quotes      
Zydus Lifesciences Ltd.
  Industry : Pharmaceuticals & Drugs
BSE Code 532321
ISIN Demat INE010B01027
Book Value 215.08
NSE Code ZYDUSLIFE
Dividend Yield % 1.19
Market Cap 934036.70
P/E 19.36
EPS 47.96
Face Value 1  
BSE NSE
18-Nov-2025
Last Price 928.25
Net Change -6.05
% Change -0.65%
Prev.Close 934.30
Open 940.05
High 940.05
Low 926.80
Volume 9386
Value 8734195
Best Buy 0.00
Best Sell 0.00
Best Quantity 0
Sell Quantity 0
Today's Range 940.05
52-Week High 1059.00
52-Week Low 797.05
Today | 1W | 1M | 1Y  
You need to upgrade your Flash Player
Best Bid Best Offer
Quantity 0
Price 0.00
Quantity 0
Price 0.00
Holding Details
More
Latest Corporate Events
Bonus 1 : 2   05-Apr-10  
Book Closure 30-Jul-21   06-Aug-21  
Dividend 1100 %   25-Jul-25  
Company News
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.